Patent Grant
9587139
The present disclosure broadly relates to curable compositions, methods of making curable compositions, and composite articles including cured curable compositions.
Polyureas are polymers derived from the reaction product of a polyisocyanate and a polyamine through step-growth polymerization. For use in protective coatings, the polyurea is crosslinked by using polyisocyanates and/or polyamines that have functionality greater than 2 (e.g., polyisocyanates with an average of >2 isocyanate group per polyisocyanate).
Polyureas' physical properties, ease of application, and ability to be used directly on steel, polyurethane foam, or mineral wool, make them suitable as anticorrosion sealants and coatings for use in oil and gas, potable water pipelines, waste water pipelines, steam lines, cooling systems, flooring, mining, and roofing.
Despite the availability of good quality polyurea resins, there remains a need for improved physical properties for many of the above applications.
In one aspect, the present disclosure provides a curable composition comprising components:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
In another aspect, the present disclosure provides, a method of coating a substrate, the method comprising coating a curable composition onto a surface of a substrate, and at least partially curing the curable composition, wherein the curable composition comprises components:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
In yet another aspect, the present disclosure provides a composite article comprising a coating disposed on a substrate, wherein the
coating is prepared from components comprising:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
Advantageously and unexpectedly, inclusion of component c) in the curable composition improves physical properties (e.g., flexural modulus and tensile modulus) of the resulting polyurea after curing. Curable compositions according to the present disclosure are useful, for example, for those applications where strength and flexibility are important properties.
In some embodiments, curable compositions according to the present disclosure are suitable for application to internal pipeline surfaces so as to form an impervious lining suitable for contact with drinking water.
The features and advantages of the present disclosure will be further understood upon consideration of the detailed description as well as the appended claims.
In all cases, the disclosure is presented by way of representation and not limitation. It should be understood that numerous other modifications and embodiments can be devised by those skilled in the art, which fall within the scope and spirit of the principles of the disclosure. The figures may not be drawn to scale.
Curable compositions according to the present disclosure typically have relatively short open times before curing advances sufficiently that the at least partially cured composition cannot be practically handled. Accordingly, they may be stored in two-part form until just prior to use. For example, components a) and b) can be separated and incorporated into respective Part A and Part B compositions. Component c), and any additional components that may be present, are typically included in PART A, PART B, or both, although it may be supplied separately. Mixing PART A with PART B forms a curable composition according to the present disclosure, which typically begins to spontaneously react to formureylene (i.e., —NR—C(O)—NR′—) groups, wherein R and R′ independently represent H or a monovalent organic group. Polymers containing ureylene groups are often referred to as polyureas. If the curable composition comprises other isocyanate reactive (e.g., —OH) or amine reactive components, the reacted coating may comprise other groups as well.
The curable composition comprises at least one aliphatic polyisocyanate. As used herein, the term “polyisocyanate” refers to any organic compound that has two or more reactive isocyanate (i.e., —N═C═O) groups in a single molecule such as, for example, diisocyanates, triisocyanates, and tetraisocyanates. Cyclic and/or linear polyisocyanate molecules may usefully be employed.
Exemplary aliphatic polyisocyanates include derivatives of hexamethylene-1,6-diisocyanate; 2,2,4-trimethylhexamethylene diisocyanate; isophorone diisocyanate; and 4,4′-dicyclohexylmethane diisocyanate. Reaction products and prepolymers of aliphatic polyisocyanates may be also be utilized as long as they contain a plurality of isocyanate groups.
Aliphatic polyisocyanates typically comprise one or more derivatives of hexamethylene-1,6-diisocyanate (HDI). In some embodiments, the aliphatic polyisocyanate is a derivative of isophorone diisocyanate. In some embodiments, the aliphatic polyisocyanate may comprise a uretdione, biuret, and/or trimer (e.g., isocyanurate) of HDI.
In some embodiments, the curable composition is substantially solvent-free (i.e., at least 95 percent by weight free of solvent) and/or substantially free of (i.e., less than 0.5 percent by weight) 1,6-hexanediisocyanate (HDI). Various solvent-free aliphatic polyisocyanate(s) are available. One type of HDI uretdione polyisocyanate, is available from Bayer Corp. USA, Pittsburgh, Pa. under the trade designation DESMODUR N 3400. Another HDI polyisocyanate is a trimer, reported to have a viscosity of about 1200 millipascal-seconds (mPa·s) at 23° C., which is available from Bayer under the trade designation DESMODUR N 3600. Such polyisocyanates typically have an isocyanate content of 20-25 percent by weight. Another polyisocyanate is an aliphatic prepolymer resin comprising ether groups, based on HDI, reported to have a viscosity of 2500 mPa·s at 23° C. is available from Bayer Corp. USA under the trade designation DESMODUR XP 2599. Yet another aliphatic polyisocyanate resin based on HDI is available from Bayer Corp. USA under the trade designation DESMODUR N3800. This material has an NCO content of 11 percent by weight and a viscosity of 6000 mPa·s at 23° C. Yet another aliphatic polyisocyanate resin based on HDI and isophorone diisocyanate is available from Bayer Corp. USA under the trade designation DESMODUR NZ1. This material has an NCO content of 20 percent by weight and a viscosity of 3000 mPa·s at 23° C.
Preferably, the curable composition comprises a mixture of an aliphatic polyisocyanate prepolymer having a viscosity of at least 2000 or 2500 mPa·s at 23° C. such as, for example, DESMODUR XP 2599, in combination with a lower viscosity polyisocyanate having a viscosity of no greater than 1500 mPa·s at 23° C. such as, for example, DESMODUR N 3600. The lower viscosity aliphatic polyisocyanate prepolymer is typically present at a weight ratio ranging from about 1:1 or 2:1 to 4:1 with a ratio of about 3:1 being preferred, although other ratios may also be used.
In another embodiment, the curable composition comprises a mixture of first aliphatic polyisocyanate prepolymer having a viscosity of at least 2000 or 2500 mPa·s at 23° C., such as, for example, DESMODUR XP 2599, in combination with a higher viscosity polyisocyanate, having a viscosity of at least 3000 mPa·s at 23° C. such as, for example, DESMODUR NZ1. The higher viscosity polyisocyanate is typically present at a weight ratio ranging from about 2:1 to 1:2 with a ratio of about 2:1 being preferred, although other ratios may also be used.
In yet another embodiment, the curable composition comprises a three-component mixture of aliphatic polyisocyanates. The three component mixture may comprise at least one trimer such as, for example, DESMODUR N 3600, and at least one aliphatic prepolymer resin comprising ether groups such as, for example, DESMODUR XP 2599.
In some embodiments, the curable composition is substantially free of (i.e., containing less than 0.5 percent by weight, preferably less than 0.1 percent by weight) nonaliphatic polyisocyanate-based amine-reactive resin(s) (e.g., aromatic polyisocyanates, monoisocyanates, and epoxy resins). For example, the curable composition is preferably free of aromatic polyisocyanates. The curable composition may be free of epoxy functional compounds and compounds containing unsaturated carbon-carbon bonds capable of undergoing Michael Addition with polyamines, (e.g., monomeric or oligomeric polyacrylates).
The curable composition comprises at least one aliphatic polyamine. As used herein, “polyamine” refers to compounds having at least two amino groups, each containing at least one active hydrogen (N—H group) selected from primary amino and secondary amino groups. In some embodiments, the polyamine(s) is/are present in PART B of the abovementioned two-part system. In some embodiments, PART B comprises or consists solely of one or more aliphatic polyamines.
Exemplary aliphatic polyamines include aliphatic primary polyamines, aliphatic secondary polyamines, and combinations thereof.
Exemplary aliphatic primary polyamines include poly(oxypropylene)diamines (e.g., as available under the trade designations JEFFAMINE D-230 and JEFFAMINE D-400 from Huntsman, The Woodlands, Tex.) poly(oxypropylene)triamines (preferably with a molecular weight in the range of 400-5000 g/mol), 1,4-diaminobutane, 1,2-ethylenediamine, 1,2-diaminopropane, and 1,3-diaminopropane.
Exemplary secondary amines include cyclic aliphatic secondary diamines, non-cyclic aliphatic secondary diamines. Additional exemplary secondary amines include aspartic ester polyamines.
In one embodiment, useful cyclic aliphatic secondary diamines comprise two, optionally substituted, hexyl groups bonded by a bridging group. Each of the hexyl rings comprises a secondary amine substituent. The aliphatic cyclic secondary diamines may be represented by the structure
wherein R1 and R2 independently represent linear or branched alkyl groups, having 1 to 10 carbon atoms. R1 and R2 are typically the same alkyl group. Representative alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, secondary butyl, tertiary butyl, and the various isomeric pentyl, hexyl, heptyl, octyl, nonyl, and decyl groups. Preferably, R1 and R2 contain at least three carbons, and the butyl group is particularly preferred (e.g., sec-butyl group). R3, R4, R5 and R6 independently represent hydrogen or a linear or branched alkyl group containing 1 to 5 carbon atoms. R3 and R4 are typically the same alkyl group. In some embodiments, R5 and R6 are hydrogen. Further, in some embodiments, R3 and R4 are methyl or hydrogen.
The substituents are represented such that the alkylamino group may be placed anywhere on the ring relative to the CR5R6 bridging group. Further, the R3 and R4 substituents may occupy any position relative to the alkylamino groups. In some embodiments, the alkylamino groups are at the 4,4′-positions relative to the CR5R6 bridging group. In some embodiments, R3 and R4 occupy the 3- and 3′-positions. Commercially available aliphatic cyclic secondary diamines having this structure include those available as CLEARLINK 1000 and CLEARLINK 3000 from Dorf Ketal Chemicals LLC, Stafford, Tex.
In another embodiment, useful aliphatic cyclic secondary diamines comprise a single hexyl ring. The aliphatic cyclic secondary diamine typically has the general structure:
wherein R7 and R8 are independently linear or branched alkyl groups, having 1 to 10 carbon atoms or an alkylene group terminating with a —CN group. R7 and R8 are typically the same group. Representative alkyl groups include the same as those described above for R1 and R2. In one embodiment, R7 and R8 are alkyl groups having at least three carbons, such as isopropyl. In another embodiments, R7 and R8 are short chain (e.g., C1-C4) alkylene groups terminating with a —CN group.
R9, R10 and R11 are independently hydrogen or a linear or branched alkyl group having 1 to 5 carbon atoms. R9, R10 and R11 are typically the same alkyl group. In some embodiments, R9, R10 and R11 are methyl or hydrogen. In one embodiment R9, R10 and R11 are methyl groups.
The substituents are represented such that the alkylamino group —NR7 may be placed anywhere on the ring relative to the —CH2NR8 group. In some embodiments, the alkylamino group is 2 or 3 positions away from the —CH2NR8 group. Preferably, —CH2NR8 group is two positions away from the —NR7 group on the cyclohexane ring. A commercially available cycloaliphatic secondary diamine having this structure is available as JEFFLINK 754 from Huntsman, The Woodlands, Tex.
Useful aliphatic cyclic secondary diamines can be prepared by reaction of isophorone diamine and a compound having a Michael acceptor group that reduces the nucleophilicity of the resulting secondary amine groups. Representative Michael acceptors include acrylonitrile and α,β-unsaturated carbonyl compounds, with acrylonitrile typically preferred. In some embodiments, the alkylene group between the terminal —CN group and the amine group has at least two carbon atoms. Commercially available aliphatic cyclic secondary diamines having this structure include HXA CE 425 from Hanson Group LLC., Alpharetta, Ga., and BAXXODUR PC-136 from BASF, Florham Park, N.J.
Exemplary non-cyclic aliphatic secondary diamines include, e.g., N,N′-bis(3′,3′-dimethylbutan-2-yl)-1,6-diaminohexane (e.g., as available under the trade designation ETHACURE 90, Albemarle Corporation, Baton Rouge, La.).
Aspartic ester polyamines are polyamines with secondary amino groups that can be produced, for example, by addition of primary aliphatic diamines to maleic or fumaric acid dialkyl esters, or by addition of primary aliphatic amines to unsaturated oligoesters or polyesters. Useful aspartic ester polyamines include, for example, aspartic ester polyamines have the general formula
wherein R12 is a divalent organic group (e.g., having up to 40 carbon atoms), each R12 is independently an organic group inert toward isocyanate groups at temperatures of 100° C. or less, and each R13 independently represents a lower alkyl group having 1 to 4 carbon atoms. For example, R13 may be methyl, ethyl, propyl, or butyl.
Preferably, R12 represents a divalent aliphatic group (preferably having 1 to 20 carbon atoms), which can be, for example, branched, unbranched, or cyclic. More preferably, R12 is selected from divalent hydrocarbon groups obtained by the removal of the amino groups from 1,4-diaminobutane, 1,6-diaminohexane, 2,2,4- and 2,4,4-trimethyl-1,6-diaminohexane, 1-amino-3,3,5-trimethyl-5-aminomethylcyclohexane, 4,4′-diamino-dicyclohexylmethane or 3,3-dimethyl-4,4′-diamino-dicyclohexylmethane. In some embodiments, R12 a branched C4 to C12 alkylene group.
Suitable aspartic ester amine resins are commercially available from Bayer Corp. under the trade designations DESMOPHEN NH 1420, DESMOPHEN NH 1520, and DESMOPHEN NH 1220. DESMOPHEN NH 1420 resin is substantially composed of the following compound
DESMOPHEN NH1520 resin is substantially composed of the following compound
DESMOPHEN NH 1220 is substantially composed of the following compound
The inclusion of aspartic ester polyamines, wherein R12 is a branched or unbranched group lacking cyclic structures and having less than 12, 10, 8, or 6 carbon atoms, is typically preferred for faster film set times of 2 to 5 minutes. The inclusion of an aspartic ester polyamine wherein R12 comprises unsubstituted cyclic structures can be employed to extend the film set time to 5 to 10 minutes. The inclusion of an aspartic ester polyamine wherein R12 comprises substituted cyclic structures can even further extend the film set time. Typically, such aspartic ester polyamines are employed at only small concentrations is combination with another aspartic ester polyamine that provides faster film set times, as just described, although this is not a requirement.
The aliphatic polyamine(s) may be combined with one or more aromatic polyamines for the purposes of adjusting the set time of the composition and adjusting the mechanical properties of the cured composition. In some embodiments, the coating composition further comprises at least one aromatic polyamine that is a solid at ambient temperature (25° C.). Suitable solid aromatic polyamines include alkyl anilines such as 4,4′-methylenebis(2-isopropyl-6-methylaniline) commercially available from Lonza under the trade designation LONZACURE M-MIPA; 4,4′-methylenebis(2,6-diisopropylaniline) commercially available from Lonza under the trade designation LONZACURE M-DIPA; 4,4′-methylenebis(2-ethyl-6-methylaniline); and 4,4′-methylenebis(3-chloro-2,6-diethylaniline) commercially available from Lonza, Basel, Switzerland under the trade designation LONZACURE MCDEA.
The aspartic ester polyamine and aromatic polyamine may be chosen such that the aromatic polyamine is dissolved in the liquid aspartic ester polyamine. aspartic ester polyamines, such as DESMOPHEN NH 1220, can exhibit high solvency for solid aromatic amines. In some embodiments, up to about 50 percent by weight of a solid aromatic amine such as an alkylaniline can be dissolved in the aspartic ester polyamine. In other embodiments, the second part comprises at least about 5 or 10 percent by weight and typically no greater than 15 percent by weight of a solid aromatic amine or a cycloaliphatic secondary amine.
A wide range of formulations are possible, such as exemplified in the forthcoming examples, depending on the desired mechanical properties and set time of the coating.
Curable compositions according to the present disclosure include from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined. In some embodiments, the curable compositions include from 9 to 16 percent by weight of at least one liquid compound, preferably from 10 to 15 percent by weight of the at least one liquid compound, based on the total weight of components a), b) and c) combined.
Each compound of the at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and n represents an integer ≧1 (e.g., 1, 2, 3, 4, 5, or 6). In some embodiments, Z has from one to 30 carbon atoms. Z may comprise, for example, alkylene, oxycarbonyl, carbonyloxy, aminocarbonyl, carbonylamino, arylene, oxygen, sulfur, alkylamino, or a combination thereof. In some embodiments, Z represents —CH2OH or —C(═O)OCH2CH2OCH2CH2OCH2CH2OC(═O)—. Commercially available liquid compounds c) include hydroabietyl alcohol and its derivatives such as, for example, ABITOL E hydroabietyl alcohol and STAYBELITE ESTER 3-E ester of hydrogenated resins marketed by Eastman Chemical Co., Kingsport, Tenn.
The first and/or second part may comprise various additives. For example, pigments, dispersing and grinding aids, water scavengers, thixotropes, defoamers, etc. can be added to improve the manufacturability, the properties during application and/or the shelf-life.
The stoichiometry of the polyurea reaction is based on a ratio of equivalents of isocyanate (e.g. modified isocyanate and excess isocyanate) of the first component to equivalents of amine of the second component. The first and second components are reacted at a stoichimetric ratio of at least about 1:1. Typically, the NCO equivalent ratio of aliphatic polyamine to aliphatic polyisocyanate (i.e., isocyanate equivalents/amine equivalents) is in a ratio of from 0.5 to 2.0, preferably in a ratio of from 0.8 to 1.5, although other ratios may also be used.
As a two-part formulation, PART A is preferably combined with PART B at a volume ratio of about 1:1, although this is not a requirement. PART A and PART B are preferably both liquids at temperatures ranging from 5° C. to 25° C. Preferably, both PART A and PART B are substantially free of any volatile solvent. That is to say, solidification of the system is not necessitated by drying or evaporation of solvent from either part of the system. To further lower the viscosity, one or both parts can be heated. Further, the coating composition has a useful shelf life of at least 6 months, more preferably, at least one year, and most preferably, at least two years.
Curable compositions according to the present disclosure are useful, for example, for coating a substrate. Typically, this is done by combining two-or more components (e.g., PART A and PART B) in a spray head and then spraying the curable composition (e.g., in the case of highly reactive systems), although for less reactive curable compositions other coating techniques may be suitable (e.g., a brush, spray gun, knife coater, or roller).
Referring now to
Suitable substrates may comprise one or more metal (e.g., steel), glass, fabric (e.g., geotextile fabric), ceramic, concrete, wood, plastic, earth. or a combination thereof. Curable compositions according to the present disclosure are suitable for use to generate pipe coatings (e.g., linings and/or exterior coatings of water distribution pipes). The curable composition may be applied directly to the surface of the substrate (e.g. internal surface and/or external surface of a pipe) without a primer layer applied to the surface.
The curable composition can be prepared by combining the constituent components, for example, using a mechanical stirrer, by hand stirring (e.g., using tongue depressor), shaking, or any other suitable technique. For rapid cure compositions spray mixing/coating techniques may be useful. This can be done using various spray coating techniques. Typically, the amine component (Part B) and the isocyanate component (Part A) are applied using a spraying apparatus that allows the components to combine immediately prior to exiting the apparatus.
Part A (e.g., including component a)) and Part B (e.g., including components b) and any additional components of the curable composition) are fed independently, e.g., by flexible hoses, to a spraying apparatus capable of being propelled through an existing pipeline to be renovated. For example, a remote controlled vehicle, such as described in U.S. Pat. Appl. Publ. No. 2006/0112996 a1 (Poole), may enter the pipeline to convey the spraying apparatus through the pipeline. The apparatus may heat the two parts of the system prior to application to the pipeline interior and mixes the two parts immediately before applying the mixture to the interior surface of the pipeline. The mixture of the two parts cures on the interior surface of the pipeline to form a (e.g. monolithic) water impervious lining. Such linings may be formed when the pipeline is initially laid, or after a period of use when the pipeline itself begins to deteriorate. Notably, the composition described herein can be applied at a caliper of at least 5 mm in a single pass forming a cured continuous lining.
A variety of spray systems may be used in conjunction with curable compositions according to the present disclosure, for example, as described in the art. In some embodiments, a heated airless spray apparatus, such as a centrifugal spinning head may be used. An airless, impingement mixing spray system generally includes the following components: a proportioning section which meters the two components and increases the pressure to above about 1500 psi (10.34 MPa); a heating section to raise the temperatures of the two components (preferably, independently) to control viscosity; and an impingement spray gun which combines the two components and allows mixing just prior to atomization. In other embodiments, a heated air vortex spray apparatus can be used to apply the coating.
In some embodiments and in particular when the liquid mixture is applied by spraying, the first and second part typically each have a (Brookfield) viscosity ranging from about 10 mPa·s to about 60000 mPa·s, using spindle 6 at the temperature at which the liquid mixture is applied. The temperature at which the liquid mixture is applied typically ranges from about 15° C. to 50° C.
Viscosity behavior of the each of the two components (i.e., PART A and PART B) is important for two part spray-coating processes. With impingement mixing, the two parts should be as close as possible in viscosity at high shear rates to allow adequate mixing and even cure. The plural component static mix/spray system appears to be more forgiving of viscosity differences between the two components. Characterization of viscosities as functions of shear rate and temperature can help with decisions as to starting point for temperatures and pressures of the coatings in the two part spray equipment lines.
In a first embodiment, the present disclosure provides a curable composition comprising components:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
In a second embodiment, the present disclosure provides a curable composition according to the first embodiment, wherein Z represents —CH2OH or —C(═O)OCH2CH2OCH2CH2OCH2CH2C(═O)—.
In a third embodiment, the present disclosure provides a curable composition according to the first or second embodiment, wherein said at least one aliphatic polyamine comprises an aspartic ester.
In a fourth embodiment, the present disclosure provides a curable composition according to the first or second embodiment, wherein said at least one aliphatic polyamine includes an aliphatic polyamine represented by the formula
wherein R1 and R2 independently represent an alkyl group having 1 to 10 carbon atoms, and R3, R4, R5, and R6 independently represent hydrogen or an alkyl group having 1 to 5 carbon atoms.
In a fifth embodiment, the present disclosure provides a curable composition according to the fourth embodiment, wherein R1 and R2 are independently alkyl groups comprising at least 2 carbon atoms.
In a sixth embodiment, the present disclosure provides a curable composition according to the fourth or fifth embodiment, wherein R3 and R4 are methyl or hydrogen.
In a seventh embodiment, the present disclosure provides a curable composition according to any one of the fourth to sixth embodiments, wherein R5 and R6 are hydrogen.
In an eighth embodiment, the present disclosure provides a curable composition according to the first or second embodiment, wherein each said at least one aliphatic polyamine has the general formula:
wherein R7 and R8 independently represent an alkyl group having from 1 to 10 carbon atoms, or a cyanoalkyl group having from 1 to 10 carbon atoms, and wherein R9, R10, and R11 are independently hydrogen or an alkyl group having from 1 to 5 carbon atoms.
In a ninth embodiment, the present disclosure provides a curable composition according to the eighth embodiment, wherein R7 and R8 are independently alkyl groups comprising at least 3 carbon atoms.
In a tenth embodiment, the present disclosure provides a curable composition according to the eighth or ninth embodiment, wherein R9, R10 and R11 are independently an alkyl group having from 1 to 5 carbon atoms.
In an eleventh embodiment, the present disclosure provides a curable composition according to the eighth or ninth embodiment, wherein R9, R10 and R11 are independently hydrogen, methyl, or isopropyl.
In an twelfth embodiment, the present disclosure provides a curable composition according to any one of the first to eleventh embodiments, wherein the at least one aliphatic polyisocyanate comprises a trimer of 1,6-hexanediisocyanate.
In an thirteenth embodiment, the present disclosure provides a method of coating a substrate, the method comprising coating a curable composition onto a surface of a substrate, and at least partially curing the curable composition, wherein the curable composition comprises components:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
In a fourteenth embodiment, the present disclosure provides a method according to the thirteenth embodiment, wherein Z represents —CH2OH or —C(═O)OCH2CH2OCH2CH2OCH2CH2C(═O)—.
In a fifteenth embodiment, the present disclosure provides a method according to the thirteenth or fourteenth embodiment, wherein said at least one aliphatic polyamine comprises an aspartic ester.
In a sixteenth embodiment, the present disclosure provides a method according to the thirteenth or fourteenth embodiment, wherein said at least one aliphatic polyamine includes an aliphatic polyamine represented by the general formula
wherein R1 and R2 independently represent an alkyl group having 1 to 10 carbon atoms, and R3, R4, R5, and R6 independently represent hydrogen or an alkyl group having 1 to 5 carbon atoms.
In a seventeenth embodiment, the present disclosure provides a method according to the sixteenth embodiment, wherein R1 and R2 are independently alkyl groups comprising at least 2 carbon atoms.
In an eighteenth embodiment, the present disclosure provides a method according to the sixteenth or seventeenth embodiment, wherein R3 and R4 are methyl or hydrogen.
In a nineteenth embodiment, the present disclosure provides a method according to any one of the sixteenth to eighteenth embodiments, wherein R5 and R6 are hydrogen.
In a twentieth embodiment, the present disclosure provides a method according to the thirteenth or fourteenth embodiment, wherein each said at least one aliphatic polyamine has the general formula:
wherein R7 and R8 independently represent an alkyl group having from 1 to 10 carbon atoms, or a cyanoalkyl group having from 1 to 10 carbon atoms, and wherein R9, R10, and R11 are independently hydrogen or an alkyl group having from 1 to 5 carbon atoms. In a twenty-first embodiment, the present disclosure provides a method according to the twentieth embodiment, wherein R7 and R8 are independently alkyl groups comprising at least 3 carbon atoms.
In a twenty-second embodiment, the present disclosure provides a method according to the twentieth or twenty-first embodiment, wherein R9, R10, and R11 are independently an alkyl group having from 1 to 5 carbon atoms.
In a twenty-third embodiment, the present disclosure provides a method according to the twentieth or twenty-first embodiment, wherein R9, R10, and R11 are independently hydrogen, methyl, or isopropyl.
In a twenty-fourth embodiment, the present disclosure provides a method according to any one of the thirteenth to twenty-third embodiments, wherein the at least one aliphatic polyisocyanate comprises a trimer of 1,6-hexanediisocyanate.
In a twenty-fifth embodiment, the present disclosure provides a composite article comprising a coating disposed on a substrate, wherein the coating is prepared from components comprising:
a) at least one aliphatic polyisocyanate;
b) at least one aliphatic polyamine; and
c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined, wherein each compound of said at least one liquid compound is independently represented by the formula:
wherein Z represents an n valent organic group, and
n represents an integer ≧1.
In a twenty-sixth embodiment, the present disclosure provides a composite article according to the twenty-fifth embodiment, wherein Z represents —CH2OH or —C(═O)OCH2CH2OCH2CH2OCH2CH2C(═O)—.
In a twenty-seventh embodiment, the present disclosure provides a composite article according to the twenty-fifth or twenty-sixth embodiment, wherein said at least one aliphatic polyamine comprises an aspartic ester.
In a twenty-eighth embodiment, the present disclosure provides a composite article according to the twenty-fifth or twenty-sixth embodiment, wherein said at least one aliphatic polyamine includes an aliphatic polyamine represented by the general formula
wherein R1 and R2 independently represent an alkyl group having 1 to 10 carbon atoms, and R3, R4, R5, and R6 independently represent hydrogen or an alkyl group having 1 to 5 carbon atoms.
In a twenty-ninth embodiment, the present disclosure provides a composite article according to the twenty-eighth embodiment, wherein R1 and R2 are independently alkyl groups comprising at least 2 carbon atoms.
In a thirtieth embodiment, the present disclosure provides a composite article according to the twenty-eighth or twenty-ninth embodiment, wherein R3 and R4 are methyl or hydrogen.
In a thirty-first embodiment, the present disclosure provides a composite article according to any one of the twenty-eighth to thirtieth embodiments, wherein R5 and R6 are hydrogen.
In a thirty-second embodiment, the present disclosure provides a composite article according to the twenty-fifth or twenty sixth embodiment, wherein each said at least one aliphatic polyamine has the general formula:
wherein R7 and R8 independently represent an alkyl group having from 1 to 10 carbon atoms, or a cyanoalkyl group having from 1 to 10 carbon atoms, and wherein R9, R10, and R11 are independently hydrogen or an alkyl group having from 1 to 5 carbon atoms.
In a thirty-third embodiment, the present disclosure provides a composite article according to the thirty-second embodiment, wherein R7 and R8 are independently alkyl groups comprising at least 3 carbon atoms.
In a thirty-fourth embodiment, the present disclosure provides a composite article according to the thirty-second or thirty-third embodiment, wherein R9, R10, and R11 are independently hydrogen or an alkyl group having from 1 to 5 carbon atoms.
In a thirty-fifth embodiment, the present disclosure provides a composite article according to the thirty-second or thirty-third embodiment, wherein R9, R10, and R11 are independently hydrogen, methyl, or isopropyl.
In a thirty-sixth embodiment, the present disclosure provides a composite article according to any one of the twenty-fifth to thirty-fifth embodiments, wherein the at least one aliphatic polyisocyanate comprises a trimer of 1,6-hexanediisocyanate.
Objects and advantages of this disclosure are further illustrated by the following non-limiting examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details, should not be construed to unduly limit this disclosure.
Unless otherwise noted, all parts, percentages, ratios, etc. in the Examples and the rest of the specification are by weight.
Abbreviations and descriptions of materials used in the Examples are given in Table 1 (below).
Flexural Modulus and Strength ASTM D790-07
Flexural modulus and strength tests were run according to test method ASTM D790-07 “Standard Test Methods for Flexural Properties of Unreinforced and Reinforced Plastics and Electrical Insulating Materials.” An Instron test station (Model II22, equipped with a 5 kN load cell, obtained from Instron, Norwood, Mass.) was used along with Bluehill software (obtained from Instron) to report both values. The test specimens were 120 mm×10 mm×4 mm injection molded bars (closed TEFLON fluoropolymer molds or open silicone molds). The support span was 64 mm and the crosshead speed was 1.7 mm/min.
Comparative Example C1 compositions were prepared by mixing an isocyanate-containing component with an amine-containing component. The amine-containing component was prepared by combining 22.00 grams (g) PA-1 and 1.94 g MM-3 in a small plastic cup for use in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer obtained from FlackTek, Inc Landrum, S.C. The cup was placed in the mixer and mixed at 3500 rounds-per-minute (rpm) for 5 minutes or until homogeneous mixtures were obtained.
The isocyanate-containing component was then added to the amine-containing component using a syringe after weighing the delivered amount (14.43 g PI-1) by difference so that the stoichiometric ratio of the amine to isocyanate was 1.0. The mixture vessel was then placed in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer and mixed for 30 seconds at 2750 rpm. Mixtures were poured into a silicone mold to generate parts having dimensions suitable for flexural testing. The parts were allowed to cure for 16 hrs, removed from the mold and placed in a desiccator for 7 days. Flexural properties were measured in accordance to ASTM D790-07 as described above, and are reported in Table 2.
Comparative Examples C2-C4 compositions were prepared in the same manner as Comparative Example C1, except that the amine-containing component was prepared by adding 22.00 g PA-1 and 4.06 g MM-3 for Comparative Example C2, 22.00 g PA-1 and 15.65 g MM-3 for Comparative Example 3, and 22.00 g PA-1 for Comparative Example 4.
Flexural properties were measured in accordance to ASTM D790-07 as described above, and are reported in Table 2.
Examples 1-2 were prepared in the same manner as Comparative Example 1, except that the amine-containing component was prepared by combining 22.00 g PA-1 and 1.92 g MM-1 for Example 1, 22.00 g PA-1 and 4.06 g MM-1 for Example 2, and 22.00 g PA-1 and 15.65 g MM-1 for Comparative Example C7, in a small plastic cup and mixing in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer at 2750 rpm for 5 minutes or until homogeneous mixtures were obtained.
Flexural properties of Examples 1-2 and Comparative Example C7 were measured in accordance to ASTM D790-07 as described above, and are reported in Table 2.
Examples 4-7 were prepared in the same manner as Comparative Example C1, except as noted below.
The amine-containing component was prepared by combining 22.00 g PA-1 and 4.06 g MM-1 for Example 4, 22.00 g PA-1 and 6.43 g MM-1 for Example 5, and 22.00 g PA-1 and 9.11 g MM-1 for Comparative Example C5, and 22.00 g PA-1 and 12.15 g MM-1 for Comparative Example C6.
The isocyanate-containing component was then added to the amine-containing component using a syringe after weighing the delivered amount (14.43 g PI-1) by difference so that the stoichiometric ratio of the amine to isocyanate was 1.0. The mixture vessel was then placed in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer and mixed for 15 seconds at 2750 rpm. Mixtures were poured into a silicone mold to generate parts having dimensions suitable for flexural testing. The parts were allowed to cure for 16 hrs, removed from the mold and placed in a desiccator for 7 days.
Flexural properties of Examples 4-5 and Comparative Examples C5-C6 were measured in accordance to ASTM D790-07 as described above, and are reported in Table 2.
Examples 8-10 were prepared in the same manner as Example 1 except that the amine-containing component was prepared by combining 22.00 g PA-1 and 1.92 g MM-2 for Example 8, 22.00 g PA-1 and 4.06 g MM-2 for Example 9, and 22.00 g PA-1 and 15.65 g MM-2 for Comparative Example C8.
Flexural properties of Examples 5-6 and Comparative Example C8 were measured in accordance to ASTM D790-07 as described above, and are reported in Table 2 (below), wherein “MPa” refers to megapascals.
Example 7 was prepared in the same manner as Comparative Example C5. The amine-containing component was prepared by adding 18.23 g PA-3 and 4.79 g MM-1 to a small plastic cup for use in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer. The cup was placed in the mixer and mixed at 3500 rpm for 5 minutes or until mixture was homogeneous. The mixture was then added to a barrel of a 400 mL 1:1 volume ratio dual-cartridge syringe.
The isocyanate-containing component was prepared by adding 22.78 g PI-1 and 2.16 g DM-1 to a small plastic cup for use in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer. The cup was placed in the mixer and mixed at 1750 rpm for 5 minutes or until mixture was homogeneous. The mixture was then added to the remaining barrel of the dual cartridge syringe.
Parts were generated by dispensing the cartridge using a pneumatic cartridge dispenser or mechanically driven cartridge dispensing system through a 5/16 inch (0.79 cm), 32 element static mixer made of commercially available static mixer elements such as STATOMIX MC 08-32 (available from Brandywine Materials, LLC Burlington, Mass.) into a 2-part closed fluoropolymer mold to generate parts having dimensions suitable for flexural testing in accordance to ASTM D790. Samples were removed from the mold after 5 minutes and then placed in an 80° C. oven for 45 minutes.
Example 8 was prepared in the same manner as Example 7, except for differences noted below.
The amine-containing component was prepared by combining 19.43 g PA-2 and 5.38 g MM-1 to a small plastic cup for use in a 150 DAC SPEEDMIXER dual asymmetric centrifuge mixer. The cup was placed in the mixer and mixed at 3500 rpm for 5 minutes or until mixture was homogeneous. The mixture was then added to a barrel of a 400 mL 1:1 volume ratio dual cartridge syringe.
The isocyanate-containing component was prepared by filling the remaining barrel with PI-1.
Parts were generated in the same manner as in Example 7.
Other modifications and variations to the present disclosure may be practiced by those of ordinary skill in the art, without departing from the spirit and scope of the present disclosure, which is more particularly set forth in the appended claims. It is understood that aspects of the various embodiments may be interchanged in whole or part or combined with other aspects of the various embodiments. All cited references, patents, or patent applications in the above application for letters patent are herein incorporated by reference in their entirety in a consistent manner. In the event of inconsistencies or contradictions between portions of the incorporated references and this application, the information in the preceding description shall control. The preceding description, given in order to enable one of ordinary skill in the art to practice the claimed disclosure, is not to be construed as limiting the scope of the disclosure, which is defined by the claims and all equivalents thereto.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2013/044111 | 6/4/2013 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2013/188176 | 12/19/2013 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3386942 | Bell | Jun 1968 | A |
| 3595731 | Davies | Jul 1971 | A |
| 3856749 | Hoeschele | Dec 1974 | A |
| 3900687 | Meader, Jr. | Aug 1975 | A |
| 3900688 | Thoma | Aug 1975 | A |
| 3931449 | Hirata | Jan 1976 | A |
| 4002598 | Waddill | Jan 1977 | A |
| 4036906 | Finelli | Jul 1977 | A |
| 4178427 | Waddill | Dec 1979 | A |
| 4328330 | Wellner | May 1982 | A |
| 4409266 | Wieczorrek | Oct 1983 | A |
| 4847321 | Hess | Jul 1989 | A |
| 4881951 | Wood | Nov 1989 | A |
| 5352733 | Hart | Oct 1994 | A |
| 5814398 | Kronz | Sep 1998 | A |
| 5919570 | Hostettler | Jul 1999 | A |
| 6290614 | Kennedy, III | Sep 2001 | B1 |
| 6297320 | Tang | Oct 2001 | B1 |
| 6369189 | Naderhoff | Apr 2002 | B1 |
| 6451963 | Langel | Sep 2002 | B1 |
| 6586523 | Blum | Jul 2003 | B1 |
| 6632147 | Cavallaro | Oct 2003 | B2 |
| 6730150 | Titterington | May 2004 | B1 |
| 6730353 | Robinson | May 2004 | B2 |
| 6774206 | Danielmeier | Aug 2004 | B2 |
| 6774207 | Danielmeier | Aug 2004 | B2 |
| 6790925 | Danielmeier | Sep 2004 | B2 |
| 6797789 | Davis | Sep 2004 | B2 |
| 6797798 | Johnston | Sep 2004 | B2 |
| 6903156 | Muller | Jun 2005 | B2 |
| 6905424 | Kennedy, III | Jun 2005 | B2 |
| 7001948 | Gupta | Feb 2006 | B2 |
| 7091280 | Rische | Aug 2006 | B2 |
| 7189429 | Robinson | Mar 2007 | B2 |
| 7781513 | Lucas | Aug 2010 | B2 |
| 7833575 | Gupta | Nov 2010 | B2 |
| 7927704 | Mager | Apr 2011 | B2 |
| 7980165 | Misencik | Jul 2011 | B2 |
| 8513334 | Grablowitz | Aug 2013 | B2 |
| 20030013835 | Zahariadis | Jan 2003 | A1 |
| 20040197472 | Scofield | Oct 2004 | A1 |
| 20050244628 | Turek | Nov 2005 | A1 |
| 20060112996 | Poole | Jun 2006 | A1 |
| 20060205859 | Bachon | Sep 2006 | A1 |
| 20070043197 | Posey | Feb 2007 | A1 |
| 20070049684 | Rische | Mar 2007 | A1 |
| 20070066786 | Hanson, Jr. | Mar 2007 | A1 |
| 20070078234 | Mager | Apr 2007 | A1 |
| 20070167565 | Rische | Jul 2007 | A1 |
| 20080097068 | Thiede | Apr 2008 | A1 |
| 20080200620 | Broekaert | Aug 2008 | A1 |
| 20080237356 | Singleton | Oct 2008 | A1 |
| 20090030161 | Johnston | Jan 2009 | A1 |
| 20090171040 | Griswold | Jul 2009 | A1 |
| 20090293350 | Kania | Dec 2009 | A1 |
| 20090309077 | Gupta | Dec 2009 | A1 |
| 20090326121 | Stockl | Dec 2009 | A1 |
| 20100021676 | Laubry | Jan 2010 | A1 |
| 20100076143 | Yakulis | Mar 2010 | A1 |
| 20100080920 | Lagrange | Apr 2010 | A1 |
| 20100252217 | Eberhardt | Oct 2010 | A1 |
| 20100266855 | Zukowski | Oct 2010 | A1 |
| 20110070387 | Schmidt | Mar 2011 | A1 |
| 20110129647 | Duke, Jr. | Jun 2011 | A1 |
| 20110288204 | Grablowitz | Nov 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 1252003 | Apr 1989 | CA |
| 2057124 | Feb 1993 | CA |
| 2096466 | Nov 1993 | CA |
| 2640098 | Mar 2010 | CA |
| 1322785 | Nov 2001 | CN |
| 1401717 | Mar 2003 | CN |
| 1817989 | Aug 2006 | CN |
| 650988 | May 1995 | EP |
| 806992 | Nov 1997 | EP |
| 1033440 | Sep 2000 | EP |
| 550022 | Dec 1942 | GB |
| 2006-183336 | Jul 2006 | JP |
| 2009-275071 | Nov 2009 | JP |
| 00-57962 | Oct 2000 | WO |
| WO 01-24888 | Apr 2001 | WO |
| WO 2008-098213 | Aug 2008 | WO |
| WO 2009-146227 | Dec 2009 | WO |
| WO 2010-034109 | Apr 2010 | WO |
| WO 2010-120617 | Oct 2010 | WO |
| WO 2012010558 | Jan 2012 | WO |
| WO 2012-161774 | Nov 2012 | WO |
| Entry |
|---|
| US 7,581,483, 09/2009, Hall (withdrawn) |
| STIC Search Report dated Jul. 5, 2016. |
| International Search Report for PCT International Application No. PCT/US2013/044111, mailed on Aug. 9, 2013, 3 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20150104652 A1 | Apr 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61660245 | Jun 2012 | US |
